A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
Clinical trial NCT00799864 · COMPLETED
Trial details
- NCT number
- NCT00799864
- Sponsor
- Janssen Sciences Ireland UC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2022-08-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.